TR200001977T2 - Compositions containing lipophilic glucocorticosteroid micelles - Google Patents

Compositions containing lipophilic glucocorticosteroid micelles

Info

Publication number
TR200001977T2
TR200001977T2 TR2000/01977T TR200001977T TR200001977T2 TR 200001977 T2 TR200001977 T2 TR 200001977T2 TR 2000/01977 T TR2000/01977 T TR 2000/01977T TR 200001977 T TR200001977 T TR 200001977T TR 200001977 T2 TR200001977 T2 TR 200001977T2
Authority
TR
Turkey
Prior art keywords
micelles
compositions containing
pharmaceutical composition
containing lipophilic
lipophilic glucocorticosteroid
Prior art date
Application number
TR2000/01977T
Other languages
Turkish (tr)
Inventor
Sj�quist Gabrielle
Original Assignee
Astrazeneca Ab
Sj�quist Gabrielle
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab, Sj�quist Gabrielle filed Critical Astrazeneca Ab
Publication of TR200001977T2 publication Critical patent/TR200001977T2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Dispersion Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Bu bulus, akici bir ortamda miseller ihtiva eden bir farmasötik bilesim ile ilgilidir ki burada miseller, lipofilik glukokortikosteroit ve farmasötik olarak kabul edilen tek bir sürfaktan ihtiva eder. Bulus ayrica farmasötik bilesimin hazirlanmasi için bir yöntem ve farmasötik bilesimin, insan da dahil bir memelide solunum sistemine ait alerjik ve/veya iltihapli hastaliklarin tedavisi ve/veya bagirsak hastaliklarini tedavi etmek için bir lacin hazirlanmasinda kullanimi ile de ilgilidir.This invention relates to a pharmaceutical composition containing micelles in a flowable medium, where the micelles contain lipophilic glucocorticosteroid and a single pharmaceutically acceptable surfactant. The invention also relates to a method for the preparation of the pharmaceutical composition and the use of the pharmaceutical composition in the preparation of a medicament for the treatment of allergic and / or inflammatory diseases of the respiratory system and / or intestinal diseases in a mammal, including a human.

TR2000/01977T 1997-12-22 1998-12-22 Compositions containing lipophilic glucocorticosteroid micelles TR200001977T2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9704833A SE9704833D0 (en) 1997-12-22 1997-12-22 New formulation

Publications (1)

Publication Number Publication Date
TR200001977T2 true TR200001977T2 (en) 2000-12-21

Family

ID=20409536

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/01977T TR200001977T2 (en) 1997-12-22 1998-12-22 Compositions containing lipophilic glucocorticosteroid micelles

Country Status (20)

Country Link
EP (1) EP1043973A1 (en)
JP (1) JP2001526210A (en)
KR (1) KR20010024789A (en)
CN (1) CN1283106A (en)
AR (1) AR017220A1 (en)
AU (1) AU1993599A (en)
BR (1) BR9813811A (en)
CA (1) CA2315782A1 (en)
EE (1) EE200000388A (en)
HU (1) HUP0102365A3 (en)
ID (1) ID26945A (en)
IL (1) IL136880A0 (en)
NO (1) NO20003220L (en)
NZ (1) NZ505073A (en)
PL (1) PL341361A1 (en)
SE (1) SE9704833D0 (en)
SK (1) SK9532000A3 (en)
TR (1) TR200001977T2 (en)
WO (1) WO1999032089A1 (en)
ZA (1) ZA9811461B (en)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9902674D0 (en) * 1999-07-12 1999-07-12 Astra Ab New composition
SE0000332D0 (en) * 2000-01-31 2000-01-31 Astrazeneca Ab New use
US6759398B2 (en) 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
GB0019172D0 (en) 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
US6787532B2 (en) * 2000-08-05 2004-09-07 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivatives
US6777400B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6858596B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
US6750210B2 (en) 2000-08-05 2004-06-15 Smithkline Beecham Corporation Formulation containing novel anti-inflammatory androstane derivative
US6777399B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6858593B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
SE0100901D0 (en) * 2001-03-15 2001-03-15 Astrazeneca Ab New composition
UA77656C2 (en) 2001-04-07 2007-01-15 Glaxo Group Ltd S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
JPWO2005018607A1 (en) * 2003-08-20 2007-11-01 味の素株式会社 Pharmaceutical formulations with improved solubility
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
CN100579510C (en) * 2006-04-13 2010-01-13 新疆维吾尔自治区包虫病临床研究所 Precursor micelle preparation and its production process
US8865692B2 (en) 2007-11-13 2014-10-21 Meritage Pharma, Inc Compositions for the treatment of gastrointestinal inflammation
EP3574914B1 (en) * 2007-11-13 2021-12-29 ViroPharma Biologics LLC Corticosteroid compositions
RU2519193C2 (en) * 2008-09-12 2014-06-10 Критикал Фармасьютикалс Лимитед Improving absorption of therapeutic agents through mucous membranes or skin
CN101982168B (en) * 2010-11-02 2012-05-23 山东大学 Quercetin nano-micelle preparation and preparation method thereof
CN102793678B (en) * 2011-05-26 2017-06-30 邓世明 A kind of preparation method of the Docetaxel injection without tween
DE102011108948A1 (en) * 2011-07-29 2013-01-31 Achim Göpferich Aqueous, colloidal solutions of lipophilic substances, in particular drug solutions
JP5456802B2 (en) * 2012-01-23 2014-04-02 株式会社Ｃａｃ Cell migration promoter and transdermal absorbent for wound treatment
CA2917921C (en) * 2013-07-17 2021-08-03 Council Of Scientific & Industrial Research Pharmaceutical composition for the treatment of diminution of bone tissue
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
US9931349B2 (en) 2016-04-01 2018-04-03 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
KR102086316B1 (en) * 2019-09-09 2020-03-09 한국콜마주식회사 Cosmetic composition having excellent percutaneous absorption property

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0179583A1 (en) * 1984-10-04 1986-04-30 Merck & Co. Inc. A system for enhancing the water dissolution rate and solubility of poorly soluble drugs
US4994439A (en) * 1989-01-19 1991-02-19 California Biotechnology Inc. Transmembrane formulations for drug administration
AR002009A1 (en) * 1994-12-22 1998-01-07 Astra Ab PHARMACEUTICAL COMPOSITION, PROCEDURE FOR THE MANUFACTURE OF A PROLIPOSOMA POWDER AS USED IN SUCH COMPOSITION, PROCEDURE FOR LAMANUFACTURE OF SUCH COMPOSITION, USE OF SUCH PHARMACEUTICAL COMPOSITION IN THE MANUFACTURE OF A DISPOSAL MEDICINAL PRODUCT.

Also Published As

Publication number Publication date
NZ505073A (en) 2002-09-27
WO1999032089A1 (en) 1999-07-01
AR017220A1 (en) 2001-08-22
HUP0102365A3 (en) 2002-01-28
HUP0102365A2 (en) 2001-11-28
PL341361A1 (en) 2001-04-09
EE200000388A (en) 2002-02-15
CA2315782A1 (en) 1999-07-01
AU1993599A (en) 1999-07-12
SE9704833D0 (en) 1997-12-22
IL136880A0 (en) 2001-06-14
CN1283106A (en) 2001-02-07
JP2001526210A (en) 2001-12-18
NO20003220D0 (en) 2000-06-21
KR20010024789A (en) 2001-03-26
EP1043973A1 (en) 2000-10-18
ID26945A (en) 2001-02-22
BR9813811A (en) 2000-10-03
SK9532000A3 (en) 2000-11-07
NO20003220L (en) 2000-08-22
ZA9811461B (en) 1999-06-22

Similar Documents

Publication Publication Date Title
TR200001977T2 (en) Compositions containing lipophilic glucocorticosteroid micelles
IL112667A (en) 6-substituted derivatives of mycophenolic acid their preparation and pharmaceutical compositions containing them
IL112664A (en) 4-amino derivatives of mycophenolic acid their preparation and pharmaceutical compositions containing them
MY111177A (en) Flavour-masked pharmaceutical compositions
HUP0001382A2 (en) Extended release formulations of erythromycin derivatives
DK1079806T3 (en) Preparations for the application of anti-inflammatory, in particular antiseptic agents and / or agents promoting the healing of wounds, to the upper respiratory tract and / or the ear
MX9605940A (en) Bio-aromatic compounds carrying an adamantyl group in ortho, pharmaceutical and cosmetic compositions containing them and utilization.
HUP9900605A3 (en) Lipopolyamines as transfection agents, preparation and use thereof and pharmaceutical compositions containing them
EP0841936A4 (en) Conjugation-stabilized therapeutic agent compositions, delivery and diagnostic formulations
CA2293470A1 (en) Benzimidazole derivatives
FI962154A (en) Composition for the in vivo preparation of therapeutic products
HUP9901144A2 (en) Pharmaceutical compositions containing new associations of clopidogrel and an antithrombotic agent
ES2153665T3 (en) THERAPEUTIC USES OF BACTERICIDE PROTEIN PRODUCTS / PERMEABILITY INCREMENTERS (BPI) FOR HUMAN MENINGOCOCEMIA.
FI964332A (en) Use of certain methanebisphosphonic acid derivatives to prevent prosthesis loosening and prosthesis migration
BRPI0008228B8 (en) pharmaceutical composition containing n-benzoyl staurosporine and solubilizing agents
HUP0104410A2 (en) A composition for the prevention and/or treatment of atherosclerosis
AU2002231889A1 (en) Halogenated composition, method for preparing same and uses thereof
HUP0100539A2 (en) Pharmaceutical compositions containing vitamin d and calcium, their preparation and therapeutic use
FR2746101B1 (en) BICYCLIC-AROMATIC COMPOUNDS
HUP0105481A2 (en) Pharmaceutical compositions containing clarithromycin and process for their preparation and their use
FR2746098B1 (en) BIAROMATIC PROPYNYL COMPOUNDS
TR200100637T2 (en) New natural product derivatives
EE9900034A (en) Arylcycloalkanecarboxylic esters, their use, pharmaceutical compositions and their preparation
FR2717081B1 (en) Retropeptides, antibodies to the latter, and their uses for vaccination and in vitro diagnosis.
DK1165102T3 (en) Matrix protein preparations for grafting in non-mineralized tissue